TEL AVIV, Israel--(BUSINESS WIRE)--DreaMed Diabetes Ltd., the developer of the personalized, AI- based diabetes management solution, announces a cooperation with Texas Children's Hospital by ...

PETAH TIKVA, Israel--(BUSINESS WIRE)--DreaMed Diabetes is announcing the use of its Artificial Pancreas algorithm in Medtronic’s new CE Marked MiniMed 780G Advanced Hybrid Closed Loop system.

DreaMed wins FDA clearance for AI insulin recommendation technology The cloud-based Advisor Pro software generates insulin delivery recommendations by analyzing information from continuous glucose ...

Israeli company DreaMed Diabetes AI developed Advisor Pro, a decision support system to assist healthcare providers in the management of diabetes patients with insulin pumps or injections. DreaMed ...

DreaMed Diabetes, developer of diabetes treatment and management solutions, announced today that it had signed an exclusive worldwide development and license agreement with Medtronic, the world's ...

TEL AVIV (Reuters) - Israel-based DreaMed Diabetes said on Monday it had licensed its artificial pancreas technology for integration into insulin pumps made by Medtronic. DreaMed will receive ...